Home » Yirui Bio: Net profit in 2021 is expected to increase by 236%-297% year-on-year _ Securities Times Network

Yirui Bio: Net profit in 2021 is expected to increase by 236%-297% year-on-year _ Securities Times Network

by admin
</p> <p> Yirui Bio: Net profit in 2021 is expected to increase by 236%-297% year-on-year _ Securities Times Network<br />

Home > News > e company

Yirui Bio: Net profit in 2021 is expected to increase by 236%-297% year-on-year

2022-01-19 19:56

Source: Securities Times e Company

Author: Lee Jae-san

Securities Times · e company

Lee Jae-san

2022-01-19 19:56

Securities Times e company news, Yirui Bio (300942) disclosed its performance forecast on the evening of January 19, and it is expected that the net profit in 2021 will be 220 million yuan to 260 million yuan, a year-on-year increase of 236.16%-297.28%. In the fourth quarter of 2021, affected by the high transmissibility of mutant strains such as Omicron, the global epidemic prevention and control has been upgraded, and the market demand for overseas antigen testing has grown again. The company’s orders and revenue for semi-finished products of new crown antigen detection reagents and supporting solutions have also increased, which has led to a substantial increase in performance.

Disclaimer: Securities Times strives for true and accurate information. The content mentioned in the article is for reference only and does not constitute substantive investment advice. Operational risks are based on this.

  • Securities Times APP
  • WeChat public account


  • 4089784

    Yirui Bio: Net profit in 2021 is expected to increase by 236%-297% year-on-year

    6885

    e company

    news

    1445

    Lee Jae-san

    2022-01-19

    See also  Mechanical engineering, DIHK: The extent of the "creeping migration" of companies

    You may also like

    Leave a Comment

    This site uses Akismet to reduce spam. Learn how your comment data is processed.

    This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

    Privacy & Cookies Policy